Analysts: Aegerion’s Lojuxta Shows Promise and 3 More Research Notes to Browse

Aegerion Pharmaceuticals (NASDAQ:AEGR): JPMorgan has raised its price target on Aegerion, after the CHMP took on a decidedly positive opinion on recommending the approval of Lojuxta.  The firm keeps an Overweight rating on the stock, and a price target of $88, up from $69.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

AEGR

Greenway Medical (NASDAQ:GWAY): Sterne Agee does not believe that Greenway will be able to convince enterprise-size physician practices to use the company’s technologies and services, and therefore keeps an Underperform rating on the stock.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

GWAY

Mercer (NASDAQ:MERC): CIBC has taken Mercer from Sector Perform to Sector Underperform, due to lower than expected maintenance outage at the Celgar pulp mill and higher fiber costs in Germany.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MERC

Legg Mason (NYSE:LM): Goldman Sachs has downgraded shares of Legg Mason to Sell, from Netural, citing the stock’s outperformance and a muted margin outlook for the downgrade. The price target is now $29.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

LM

Don’t Miss: Has Apple Solved the Smartphone Theft Problem?

More Articles About:    

More from The Cheat Sheet